Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.20.1
Stockholders' Equity - Stock Option Activity (Detail)
 3 Months Ended 12 Months Ended
Feb. 29, 2020
USD ($)
$ / shares
shares
Nov. 30, 2019
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 44,969  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2018 1,089,774  
Granted 44,969  
Exercised (20,000)  
Outstanding at November 31, 2019 1,114,743 1,089,774
Exercisable at November 30, 2019 1,006,623  
Outstanding at November 30, 2018, Weighted Average Exercise Price | $ / shares $ 3.30  
Granted, Weighted Average Exercise Price | $ / shares 7.26  
Exercised, Weighted Average Exercise Price | $ / shares 2.05  
Outstanding at November 30, 2019, Weighted Average Exercise Price | $ / shares 3.49 $ 3.30
Exercisable at November 30, 2019, Weighted Average Exercise Price | $ / shares $ 3.06  
Outstanding, Weighted Average Remaining Contractual Term (Years) 3 years 11 months 8 days 3 years 10 months 27 days
Exercisable at November 30, 2019, Weighted Average Remaining Contractual Term (Years) 3 years 4 months 20 days  
Outstanding at November 30, 2019 | $ $ 4,648,111  
Granted | $ 813  
Exercised | $ 102,800  
Outstanding at November 30, 2019 | $ 4,192,762 $ 4,648,111
Exercisable at November 30, 2019 | $ $ 4,191,626